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ABSTRACT Accumulating evidence suggests that intestinal bacteria promote en-
teric virus infection in mice. For example, previous work demonstrated that antibi-
otic treatment of mice prior to oral infection with poliovirus reduced viral replication
and pathogenesis. Here, we examined the effect of antibiotic treatment on infection
with coxsackievirus B3 (CVB3), a picornavirus closely related to poliovirus. We treated
mice with a mixture of five antibiotics to deplete host microbiota and examined
CVB3 replication and pathogenesis following oral inoculation. We found that, as
seen with poliovirus, CVB3 shedding and pathogenesis were reduced in antibiotic-
treated mice. While treatment with just two antibiotics, vancomycin and ampicillin,
was sufficient to reduce CVB3 replication and pathogenesis, this treatment had no
effect on poliovirus. The quantity and composition of bacterial communities were al-
tered by treatment with the five-antibiotic cocktail and by treatment with vancomy-
cin and ampicillin. To determine whether more-subtle changes in bacterial popula-
tions impact viral replication, we examined viral infection in mice treated with
milder antibiotic regimens. Mice treated with one-tenth the standard concentration
of the normal antibiotic cocktail supported replication of poliovirus but not CVB3.
Importantly, a single dose of one antibiotic, streptomycin, was sufficient to reduce
CVB3 shedding and pathogenesis while having no effect on poliovirus shedding and
pathogenesis. Overall, replication and pathogenesis of CVB3 are more sensitive to
antibiotic treatment than poliovirus, indicating that closely related viruses may differ
with respect to their reliance on microbiota.
IMPORTANCE Recent data indicate that intestinal bacteria promote intestinal infec-
tion of several enteric viruses. Here, we show that coxsackievirus, an enteric virus in
the picornavirus family, also relies on microbiota for intestinal replication and patho-
genesis. Relatively minor depletion of the microbiota was sufficient to decrease cox-
sackievirus infection, while poliovirus infection was unaffected. Surprisingly, a single
dose of one antibiotic was sufficient to reduce coxsackievirus infection. Therefore,
these data indicate that closely related viruses may differ with respect to their reli-
ance on microbiota.
KEYWORDS antibiotics, coxsackievirus, enteric viruses, microbiota, poliovirus,
viral pathogenesis
Enteric viruses are spread through the fecal-oral route and cause morbidity andmortality in humans worldwide (1–4). These viruses initiate infection in the gastro-
intestinal tract, which is home to a community of bacteria, fungi, and viruses termed
the microbiota. The microbiota plays important roles in human development, metab-
olism, and immunity (5). We and others have shown that intestinal bacteria can
enhance viral replication and pathogenesis of enteric viruses, including poliovirus,
reovirus, rotavirus, mouse mammary tumor virus, and noroviruses (6–11). While the
mechanisms underlying bacterial promotion of enteric virus replication are not entirely
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clear, several groups have shown that bacteria can enhance viral infection through
effects on host immunity and/or effects on viral particles (12). For example, we have
shown that bacterial surface polysaccharides bind to poliovirus, a member of the
Picornaviridae, and enhance virion stability and cell attachment (13). However, it is not
known whether bacteria influence the replication of other picornaviruses in vivo or
whether different antibiotic regimens equally impact replication and pathogenesis of
related viruses.
Coxsackievirus is an enteric virus in the Picornaviridae family that initiates infection
in the gastrointestinal tract. Among enteric viruses, coxsackieviruses are very common
and can cause hemorrhagic conjunctivitis; hand, foot, and mouth disease; and myo-
carditis (14–17). Coxsackievirus B3 (CVB3) shares 62.3% sequence identity with polio-
virus, a closely related picornavirus. CVB3 is the most commonly isolated virus associ-
ated with viral myocarditis (18, 19), which can lead to heart disease and heart failure.
Unfortunately, there are no vaccines or treatments for coxsackievirus infections.
Previously, we established an oral inoculation model for CVB3 to study viral repli-
cation within the gastrointestinal tract (20, 21), and here we examined whether bacteria
influence coxsackievirus infection. Similarly to our observations described in a previ-
ously published study of poliovirus (9), we found that intestinal bacteria enhance CVB3
fecal shedding and pathogenesis. However, CVB3 and poliovirus differed with respect
to their reliance on microbiota, since minimal depletion of the microbiota reduced
replication and pathogenesis of CVB3 but not poliovirus. These data suggest that CVB3
is more sensitive than poliovirus to perturbations in the microbiota.
(This article was submitted to an online preprint archive [22].)
RESULTS
Intestinal bacteria enhance CVB3 replication and pathogenesis in vivo. We
previously determined that intestinal bacteria enhance poliovirus replication and
pathogenesis in orally inoculated mice (9). To determine if bacteria enhance infection
of another closely related enteric virus, we examined CVB3 replication and pathogen-
esis in antibiotic-treated mice. To facilitate direct comparison of poliovirus and CVB3,
we performed these experiments in mice that are orally susceptible to both viruses, due
to expression of the human poliovirus receptor (PVR) and lack of the interferon
alpha/beta receptor (IFNAR) (C57BL/6 PVR/ IFNAR/ mice). Our previous work
established that, similarly to the results seen with poliovirus, immunocompetent mice
orally inoculated with CVB3 shed relatively small amounts of virus and do not develop
disease. However, orally inoculated IFNAR/ mice shed larger amounts of CVB3 and
succumb to disease via liver failure, with increased serum levels of alanine aminotrans-
ferase and liver pathology (20, 21). Here, following weeklong administration of a
combination of ampicillin, neomycin, metronidazole, vancomycin, and streptomycin,
mice were perorally inoculated with 5 107 PFU of CVB3. Feces specimens were
collected at 24, 48, and 72 h postinoculation, and CVB3 titers were determined by
plaque assay. Similarly to our observations described in a previously published study of
poliovirus (9), we found that mice treated with antibiotics showed reduced CVB3
shedding at 48 and 72 h postinoculation (Fig. 1A), reduced CVB3 titers in tissues at 72 h
postinoculation (Fig. 1B), and reduced lethality (Fig. 1C) compared to untreated mice.
These data suggest that intestinal bacteria enhance CVB3 replication and pathogenesis.
Treatment with ampicillin and vancomycin reduces CVB3 infection but not
poliovirus infection. To determine the effect of specific antibiotics on CVB3 replica-
tion, we treated mice with antibiotics administered either individually or in different
combinations prior to oral inoculation with 5 107 PFU of CVB3. Feces specimens were
collected at 72 h postinoculation, and CVB3 titers were quantified by plaque assay. We
found no difference between the CVB3 fecal titers from untreated mice and the titers
from those treated with vancomycin (Fig. 2A). In contrast, CVB3 fecal titers were
reduced in mice treated with ampicillin or ampicillin plus vancomycin compared to
untreated mice (Fig. 2A). In fact, the fecal titers in mice treated with ampicillin and
vancomycin were similar to the fecal titers in mice treated with the five-antibiotic
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cocktail. Additionally, we observed that mice treated with ampicillin and vancomycin
prior to oral inoculation were protected from CVB3-induced lethality (Fig. 2B). Overall,
these data suggest that treatment with ampicillin and vancomycin is sufficient to
reduce both CVB3 shedding and pathogenesis.
Next, we examined whether treatment with ampicillin and vancomycin would be
sufficient to reduce poliovirus replication and pathogenesis. Since our laboratory
previously determined that depletion of intestinal bacteria with a four-antibiotic cock-
tail reduced poliovirus replication and pathogenesis (9) and since CVB3 and poliovirus
are from the same viral family, we hypothesized that ampicillin and vancomycin
treatment would be sufficient to reduce poliovirus infection. To address this hypothesis,
we treated mice with ampicillin and vancomycin prior to oral inoculation with 2 107
FIG 1 Treatment with a cocktail of five antibiotics reduced CVB3 shedding and lethality. Male C57BL/6
PVR/ IFNAR/ mice were left treated or treated with a combination of 5 antibiotics (ampicillin,
neomycin, streptomycin, metronidazole, and vancomycin) for 5 days by oral gavage followed by admin-
istration in drinking water available ad libitum for 9 days prior to oral inoculation with 5 107 PFU of
CVB3. (A and B) Viral titers in feces specimens collected at 24, 48, and 72 h postinoculation (A) or tissues
collected at 72 h postinoculation (B) were determined by plaque assay. Data represent means standard
errors of the means (SEM). *, P 0.05; **, P 0.001; ***, P 0.0001 (Mann-Whitney test). (C) Survival of
untreated or antibiotic-treated mice orally inoculated with CVB3. *, P 0.05 (log rank test). n 9 to 25
mice per group from 3 to 7 independent experiments. Sm. Int, small intestine.
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PFU of poliovirus. Feces specimens were collected at 24, 48, and 72 h postinoculation,
and poliovirus titers were quantified by plaque assay. We found no significant differ-
ence in poliovirus fecal titers of untreated mice compared to those treated with
ampicillin and vancomycin (Fig. 3A). These data suggest that treatment with ampicillin
and vancomycin does not alter poliovirus replication in the intestine. However, high
fecal titers are not always indicative of poliovirus replication in the intestine (9, 20).
Input inoculum virus can be shed for a few days following infection and can confound
interpretation of viral titer data, particularly during antibiotic treatment, due to reduced
peristalsis (9, 20). Therefore, to ensure that the fecal titers detected in poliovirus-
infected mice would be due to replicated rather than input virus, we differentiated
between inoculum and replicated viruses in mouse feces by the use of light-sensitive
viruses. Poliovirus was propagated in the presence of neutral red dye to create a
light-sensitive poliovirus stock. Neutral red dye within virions confers light sensitivity
due to RNA cross-linking. Upon viral replication in the dark, such as in the gastroin-
testinal tract, progeny virions are light insensitive, which facilitates the assessment of
replication by differentiation of inoculum virus from replicated virus (9, 13, 21). Follow-
ing inoculation with light-sensitive, neutral red poliovirus, feces specimens were col-
lected at 24, 48, and 72 h postinfection in the dark. Following processing, poliovirus
replication was quantified by determining the ratio of light-exposed to dark-exposed
fecal titers. Again, in contrast to CVB3 results, we found that poliovirus replication was
not reduced in mice treated with ampicillin and vancomycin (Fig. 3B). Furthermore,
treatment of mice with ampicillin and vancomycin did not alter the survival of mice
inoculated with poliovirus (Fig. 3C). Overall, these data suggest that treatment with
ampicillin and vancomycin is sufficient to reduce CVB3 shedding and pathogenesis
while having no effect on poliovirus replication and pathogenesis.
Microbiota composition of mice treated with different antibiotic regimens. To
examine the intestinal bacterial community of mice, we analyzed fecal samples using
real-time quantitative PCR (qRT-PCR) and 16S rRNA sequencing. As expected, quanti-
tative PCR (qPCR) experiments revealed that treatment with the five-antibiotic cocktail
or vancomycin and ampicillin significantly reduced prevalences of Eubacteria (general
bacterial population; Fig. 4A), Bacteroidetes (a predominant phylum of Gram-negative
bacteria; Fig. 4B), and Firmicutes (a predominant phylum of Gram-positive bacteria; Fig.
4C). Treatment with the five-antibiotic cocktail reduced Eubacteria 16S rRNA gene copy
numbers over 80,000-fold, and treatment with ampicillin and vancomycin reduced
FIG 2 Treatment with two antibiotics, ampicillin and vancomycin, was sufficient to reduce CVB3 shedding and
lethality. Male C57BL/6 PVR/ IFNAR/ mice were left untreated or treated with various antibiotics for 5 days by
oral gavage followed by administration in drinking water available ad libitum for 9 days prior to oral inoculation
with 5 107 PFU of CVB3. (A) Viral titers in feces specimens collected at 72 h postinoculation were determined by
plaque assay. Data represent means  SEM. *, P 0.05; **, P 0.001; ***, P 0.0001 (Mann-Whitney test). Abx
cocktail, five-antibiotic cocktail. (B) Survival of untreated or ampicillin-and-vancomycin-treated mice. *, P 0.05 (log
rank test). n 12 to 17 mice per group from 3 independent experiments.
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Eubacteria 16S rRNA gene copy numbers by over 1,200-fold, and trends were similar for
Bacteroidetes and Firmicutes (Fig. 4A to C). As expected, the five-antibiotic cocktail
depleted bacteria more extensively than the ampicillin and vancomycin combination.
To identify the microbial communities in each treatment group, we performed 16S
FIG 3 Treatment with ampicillin and vancomycin had no effect on poliovirus shedding and lethality. Male
C57BL/6 PVR/ IFNAR/ mice were left untreated or treated with various antibiotics for 5 days by oral
gavage followed by administration in drinking water available ad libitum for 9 days prior to oral inoculation
with 2 107 PFU of poliovirus. (A) Viral fecal titers at 24, 48, and 72 h postinoculation were determined by
plaque assay. (B) Viral replication efficiency was examined using light-sensitive viruses. Mice were orally
inoculated with neutral red-containing, light-sensitive poliovirus in the dark, and feces specimens were
collected at 24, 48, and 72 h postinoculation in the dark. Replication status was determined by dividing the
number of PFU per milliliter of light-exposed samples (representing replicated virus) by the number of PFU
per milliliter of dark-exposed samples (representing input/nonreplicated virus plus replicated virus) and
multiplying by 100%. Data represent means  SEM. (C) Survival of untreated or ampicillin-and-vancomycin-
treated mice following inoculation with 2 107 PFU of poliovirus. The log rank test was used to assess the
results of comparisons of survival data. n 11 to 12 mice per group from 4 independent experiments.
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rRNA sequencing. We found that the overall diversity of bacteria decreased in both
mice treated with the five-antibiotic cocktail and mice treated with ampicillin plus
vancomycin (Fig. 4D). While the microbial communities in mice treated with the
five-antibiotic cocktail differed from the microbial communities in those treated with
ampicillin and vancomycin (Fig. 4E), the relative prevalences of distinct members of the
microbiota were more similar in the two antibiotic treatment groups than they were in
comparison to the untreated controls (Fig. 4F). For example, Bacteroidetes and Firmic-
utes were the most prevalent members in untreated mice, while Tenericutes predom-
inated in the two different antibiotic treatment groups. Overall, these data suggest that
both antibiotic treatment regimens alter host microbiota but that treatment with the
FIG 4 Profiling the bacterial populations present in mice treated with different antibiotic regimens. Male
C57BL/6 PVR/ IFNAR/ mice were left untreated or treated with various antibiotics for 5 days by oral
gavage followed by administration in drinking water available ad libitum for 9 days. DNA was extracted from
fecal pellets, bacteria were quantified by 16S rRNA qRT-PCR (A to C), and population diversity was determined
by 16S rRNA gene sequencing (D to F). Group qRT-PCR (copies per milligram of feces) was performed on fecal
genomic DNA collected from mice that were left untreated, treated with a cocktail of five antibiotics (Abx), or
treated with ampicillin and vancomycin (AmpVanc). (A) Eubacteria (general bacterial population). (B)
Bacteroidetes (a predominant phylum of Gram-negative bacteria). (C) Firmicutes (a predominant phylum of
Gram-positive bacteria). Panel A data are derived from mice that were subsequently infected with poliovirus
(Fig. 1) and CVB3 (Fig. 3); the bacterial profiles for the two viral infection groups were similar. Data represent
means  SEM. *, P 0.05; **, P 0.001; ***, P 0.0001; ****, P 0.00001 (Mann-Whitney test). The V3-V4
region was amplified and sequenced using Illumina sequencing, and analysis was performed on forward reads
using Qiime. (D) Faith’s phylogenetic diversity (intrasample) data determined using a rarefaction cutoff of
10,000 reads/sample. (E) A principal-component-analysis plot generated using Emporer (33). (F) Bacterial
taxonomy was assigned and visualized at the level of class.
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cocktail of antibiotics depletes microbiota to a greater extent than treatment with
ampicillin and vancomycin.
CVB3, but not poliovirus, is sensitive to relatively minor perturbations of the
microbiota. Given that treatment with just ampicillin and vancomycin was sufficient to
inhibit CVB3 infection, we hypothesized that microbiota enhancement of CVB3 infec-
tion may require relatively high numbers of bacteria. To test this, we treated mice with
milder antibiotic regimens. First, we treated immunocompetent C57BL/6 mice with
1/10 the normal dose (0.1) of the five-antibiotic cocktail and then orally infected them
with either 5 107 PFU of CVB3 or 2 107 PFU of poliovirus. Feces specimens were
harvested at 72 h postinoculation and quantified via plaque assay. We found that
treatment with the 0.1 five-antibiotic cocktail was sufficient to significantly reduce
CVB3 shedding while having no effect on poliovirus shedding (Fig. 5A). Importantly, this
experiment was performed with immunocompetent mice, indicating that the en-
hanced reliance of CVB3 on microbiota occurs in both immunocompetent and
immune-deficient (IFNAR knockout) animals. To further examine the relative levels of
dependence of CVB3 and poliovirus on microbiota, we treated C57BL/6 PVR/
IFNAR/ mice with a single dose of one antibiotic, streptomycin, 1 day prior to oral
inoculation with 5 107 PFU of CVB3 or 2 107 PFU of poliovirus. Feces specimens
were harvested at 72 h postinoculation, and viral titers were quantified via plaque
assay. We found that mice treated with one dose of streptomycin had significantly
reduced levels of CVB3 shedding, while poliovirus shedding was unaffected (Fig.
5B). Furthermore, a single dose of streptomycin was sufficient to completely rescue
mice from CVB3-associated lethality (Fig. 5C), while there was no effect on
FIG 5 CVB3 replication is more sensitive to antibiotic treatment than poliovirus replication. (A) Male C57BL/6
PVR/mice were left untreated or treated with a combination of 5 antibiotics (ampicillin, neomycin, streptomycin,
metronidazole, and vancomycin) at a 0.1 concentration (one-tenth the standard concentration) for 5 days by oral
gavage followed by a 0.1 concentration administered in drinking water available ad libitum for 9 days prior to oral
inoculation with either 5 107 PFU of CVB3 or 2 107 of poliovirus. (A) Fecal titers at 72 h postinoculation were
determined by plaque assay. (B to D) Male C57BL/6 PVR/ IFNAR/ mice were left untreated or treated with a
single gavage of streptomycin the day prior to oral inoculation with either 5 107 PFU CVB3 or 2 107 PFU
poliovirus. (B) CVB3 and poliovirus fecal titers at 72 h postinoculation determined by plaque assay. (C and D)
Survival of untreated or streptomycin-treated mice orally inoculated with CVB3 (C) or poliovirus (D). Data represent
means  SEM. *, P 0.05 (Mann-Whitney test or log rank test). n 6 to 9 mice per group from 2 independent
experiments.
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poliovirus-associated lethality (Fig. 5D). These data suggest that CVB3 is more
sensitive than poliovirus to perturbations in the microbiota and that a single dose
of one antibiotic can dramatically alter the outcome of CVB3 infection. Overall, our
data suggest that these two closely related enteric viruses have different microbiota
requirements.
DISCUSSION
Work performed in several laboratories has shown that enteric viruses from four
families benefit from intestinal bacteria, but the precise microbiota requirements
for different viruses are unclear (6–9). Here, we examined the role of bacteria on
intestinal replication and pathogenesis of coxsackievirus, an enteric virus from the
Picornaviridae family, using an oral inoculation mouse model. Not surprisingly, we
found that CVB3 infection is sensitive to antibiotic-mediated depletion of microbi-
ota (Fig. 1). This suggests that, similarly to poliovirus, bacteria promote CVB3
replication in the intestine.
Interestingly, we found that CVB3 was sensitive to relatively minor perturbations of
the microbiota whereas poliovirus was unaffected by these conditions and was able to
replicate and cause disease. For example, levels of CVB3 replication and pathogenesis
were dramatically diminished by treatment with ampicillin and vancomycin (Fig. 2), by
treatment with a lower concentration of antibiotics (Fig. 5A), or by treatment with even
a single dose of a single antibiotic (Fig. 5B to D). Poliovirus replication and pathogenesis
were not affected by any of these treatment regimens. This suggests that even closely
related enteric viruses may utilize different bacteria and/or mechanisms to enhance
intestinal replication.
It is possible that CVB3 replication is dependent on the presence of a certain
minimum number of bacteria or on the presence of a particular bacterial strain or
constellation of bacterial strains or on a combination of these factors. We examined
bacterial prevalence by 16S rRNA qPCR analysis, and we examined bacterial diversity by
16S rRNA sequence analysis. We found that the overall abundance and diversity of the
microbiota were altered during antibiotic treatment (Fig. 4). The levels of diversity of
bacterial phyla in mice administered the whole cocktail of antibiotics and in those
administered just ampicillin and vancomycin were similar (Fig. 4D to F), whereas the
relative bacterial abundances were more dramatically altered between those treatment
groups (Fig. 4A to C). Thus, it is possible that bacterial prevalence matters more than
bacterial community composition for CVB3 replication, although future experiments
will be needed to test this hypothesis.
While the precise mechanisms underlying the different microbiota requirements of
CVB3 and poliovirus are unclear, it is possible that CVB3 is more reliant on microbiota
for dampening host immune responses or enhancing the infectivity of viral particles.
Treatment with ampicillin and vancomycin was sufficient to reduce CVB3 infection, and
Baldridge et al. have shown that ampicillin and vancomycin are sufficient to regulate
the lambda interferon (IFN-) pathway and to reduce the persistence of another enteric
virus, murine norovirus (7). It remains unclear if the IFN- pathway plays a role in
bacterial enhancement of CVB3 intestinal replication. Additionally, antibiotics can
regulate the host interferon response (23) and can have noncanonical effects on enteric
viruses (24).
In conclusion, we found that, similarly to poliovirus and other enteric viruses,
bacteria enhance CVB3 replication and virus-associated lethality. Interestingly, a single
dose of a clinically relevant broad-spectrum antibiotic, streptomycin, was sufficient to
reduce CVB3 replication and completely abolish CVB3-associated lethality while having
no effect on poliovirus. This result could have implications for how standard antibiotic
treatment regimens for bacterial infections could also impact the course of enteric virus
infections.
MATERIALS AND METHODS
Cells and viruses. HeLa cells were propagated in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% calf serum. Poliovirus work was performed in areas meeting or exceeding
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biosafety level 2 standards (BSL2) in accordance with practices recommended by the World Health
Organization. Poliovirus (serotype 1 virulent Mahoney) infections and plaque assays were performed
using HeLa cells according to previously published methods (25). The CVB3-Nancy infectious clone
was obtained from Marco Vignuzzi (Pasteur Institute, Paris, France). Stocks of CVB3 were prepared
as previously described (20). CVB3 titers were determined by plaque assay with HeLa cells (20, 21).
To determine whether fecal viruses were input/inoculum virus or virus that had undergone replica-
tion, we used neutral-red-labeled, light-sensitive poliovirus as described previously (25). Light inactiva-
tion was performed by exposing neutral red-poliovirus stocks to a fluorescent light bulb for 10 min. The
ratio of light-insensitive PFU to light-sensitive PFU in the virus stock was 1 105:1.5 105. Following oral
inoculation, to determine the percentage of replicated virus in the intestine, samples were processed in
the dark and a portion was light exposed. The percentage of replicated virus was calculated by dividing
the light-exposed number of PFU per milliliter by the non-light-exposed number of PFU per milliliter and
multiplying by 100.
Mouse experiments. All animals were handled according to the Guide for the Care of Laboratory
Animals of the National Institutes of Health. All mouse studies were performed at the University of Texas
Southwestern Medical Center (UT Southwestern) (Animal Welfare Assurance no. A3472-01) using proto-
cols approved by the local Institutional Animal Care and Use Committee in a manner designed to
minimize pain, and any animals that exhibited severe disease were euthanized immediately with
isoflurane. C57BL/6 PVR/ IFNAR/ mice were obtained from S. Koike (Tokyo, Japan) (26). We used
IFNAR/ mice for these experiments since orally inoculated immunocompetent animals shed small
amounts of virus following oral inoculation and do not develop disease (9, 13, 21). Wild-type, immuno-
competent C57BL/6 PVR/ mice were used in Fig. 5A experiments. Throughout, littermate controls
and/or cage randomization of different litters were used to limit variability from microbiota differences.
For example, the mice from each cage were split into two groups—one treated with antibiotics and one
not treated with antibiotics. For the experiments whose results are presented in Fig. 5, where subtle
changes in microbiota could impact results, we split mice from each cage and infected with CVB3 or
poliovirus to allow a direct comparison of the two viruses. Mice were administered either a combination
of 5 antibiotics (ampicillin, neomycin, streptomycin, metronidazole, and vancomycin; 10 mg of each
antibiotic per day) or individual antibiotics (10 mg per antibiotic per day) for 5 days by oral gavage
followed by administration in drinking water available ad libitum (for ampicillin, neomycin, streptomycin,
and metronidazole, 1 g/liter; for vancomycin: 500 mg/liter) for the duration of the experiment. Mice were
treated with antibiotics for 9 days prior to peroral inoculation with poliovirus or CVB3. For oral inocu-
lations, 8-to-12-week-old male mice were perorally inoculated with either 5 107 PFU of CVB3 or 2 107
PFU of poliovirus. Male mice were used since CVB3 was shown to have a sex-dependent enhancement
of replication and lethality (20). Disease was monitored until day 14 postinoculation for survival
experiments. Mice were euthanized upon severe disease onset. For viral shedding and replication
experiments, feces specimens were collected at indicated time points postinoculation and processed as
previously described (9). Tissues were aseptically removed from mice and homogenized in phosphate-
buffered saline (PBS) using 0.9-to-2.0-mm-diameter stainless steel beads in a Bullet blender (Next
Advance) and freeze-thawed 3 times in liquid nitrogen to release intracellular virus. Cellular debris was
removed by centrifugation at 13,000 rpm for 3 min. The amount of virus in supernatant was determined
by plaque assay in HeLa cells, and titers were normalized to the weight of each tissue.
qRT-PCR and sequencing. DNA was extracted from fecal pellets using PowerFecal DNA (Qiagen).
The V3-V4 region of the 16S rRNA gene was amplified using primers 5=-TCGTCGGCAGCGTCAGATGTGT
ATAAGAGACAG[CCTACGGGNGGCWGCAG] (forward primer) and 5=-GTCTCGTGGGCTCGGAGATGTGTATA
AGAGACAG[GACTACHVGGGTATCTAATCC] (reverse primer) and sequenced on an Illumina MiSeq v3
sequencer using paired-end (PE) sequencing and 300 cycles. Analysis was performed on forward reads
using Qiime 1.9.1 (27). Primer sequences were trimmed from each read, and all reads were quality filtered
(Phred score  25) using the multiple_split_libraries_fastq.py command. Operational taxonomic units
(OTUs) were assigned using open-reference picking (SILVA 128 release) (28, 29) with default parameters,
except for 0.1% subsampling, as follows: for filter_alignment.py, gap filter threshold, 0.8; lane mask
filtering, true; entropy threshold, 0.10. This yielded a minimum of 134,043 and median of 238,345
sequence counts per sample. Bacterial taxonomy was assigned (30, 31) and visualized at the level of class.
Intrasample and between-sample diversity levels were calculated using core_diversity.py workflow (32).
Faith’s phylogenetic diversity (intrasample) used a rarefaction cutoff of 10,000 reads/sample. A principal-
coordinate-analysis (PCoA) plot was visualized using Emporer (33).
Statistical analysis. The differences between groups were examined by the use of the unpaired
two-tailed Student’s t test. Error bars in figures represent standard errors of the means. A P value of0.05
was considered significant. All analyses of data were performed using GraphPad Prism version 7.00 for
Windows (GraphPad Software, La Jolla, CA).
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